Evidence map›Paper›PMID 30622676›Full record

ArticleOxidative medicine and cellular longevity2018

Effects of Irbesartan Pretreatment on Pancreatic

Cuihong Chen, Li Li, Haijing Qin, Zhenxing Huang, Jing Xian, Jinwei Cai, Yingfen Qin, Jie Zhang, Xinghuan Liang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Cuihong ChenDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-3442-0797
Li LiDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-4616-8963
Haijing QinDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0003-0786-4357
Zhenxing HuangDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-2764-2674
Jing XianDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0003-1230-0978
Jinwei CaiDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-2688-9640
Yingfen QinDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0001-7715-7311
Jie ZhangDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-8541-6616
Xinghuan LiangDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID 0000-0002-2992-2098
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study was performed to investigate the effects and potential effects of irbesartan pretreatment on pancreatic

Indexed as

AnimalsAntihypertensive AgentsApoptosisIrbesartanIslets of LangerhansMaleMiceStreptozocinAntihypertensive AgentsIrbesartanStreptozocin

Identifiers

PMID30622676
PMCPMC6304884
OpenAlexW2902672905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.